Trials / Completed
CompletedNCT03010787
A First Time in Human Study in Healthy Volunteers and Patients
A Four Part, Phase 1, First Time in Human, Single Centre Study in Healthy Male Subjects, Patient Volunteers With Crohn's Disease and in Healthy Patient Volunteers With a Terminal Ileostomy
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- VHsquared Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
A multi-part study to investigate the safety, tolerability and local and systemic pharmacokinetics of V565
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | V565 | single ascending dose of V565 |
| DRUG | V565 | Multiple dose |
| DRUG | Placebo | Single and multiple dose |
| DRUG | V565 | Open-label single dose |
| DRUG | V565 | Open-label single ascending dose |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2017-01-05
- Last updated
- 2017-01-05
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03010787. Inclusion in this directory is not an endorsement.